EpiGentek

Epigentek Group Inc., established in 2005, is a leading epigenetics company dedicated to developing innovative technologies and products for epigenetics-related research and drug discovery. With a comprehensive portfolio of proprietary solutions, Epigentek aims to provide systematic and complete support to researchers in academia, pharmaceuticals, and biotechnology worldwide.

Designed for simplicity, speed, and efficiency, Epigentek’s unique products streamline assays, outperforming traditional methods in convenience and performance. These cutting-edge tools are distributed globally through a dedicated sales team and an extensive network spanning over 36 countries and regions.

Committed to customer satisfaction and experimental success, Epigentek prioritizes technological innovation and continues to expand and refine its product offerings, solidifying its position as a pioneer in the field of epigenetics.

Additional Information

Our Mission

To build and become the world-leading, complete and systematic provider of epigenetic-related products, technologies, and services through innovative and intelligent research and development. Our objectives are to: Assist researchers in solving challenges in epigenetic issues. Develop and introduce simplification and accuracy to epigenetic experiments. Ensure customer satisfaction through superior reliability, speed, service, and quality. Encourage and facilitate the study of epigenetics for potential medical applications. Pioneer and innovate epigenetic products through routine analysis of technological trends.